Big Pharma chases vaccines

Big Pharma players Johnson & Johnson, Abbott, and Merck all bet on vaccines this week by making deals for the rights to new flu vaccines.  School of Law Professor Kevin Outterson, director of the Health Law Program and an authority on drug marketing, says vaccines are hot because they’re the most expensive in history.

“With vaccines, the key is significant population coverage, so these vaccines won’t achieve their potential health gains unless the companies and governments work together to make them fully available for people who aren’t rich.”

Contact Kevin Outterson, 617-353-3103,

Post a Comment

Your email address is never shared. Required fields are marked *